The Australia New Zealand Gynaecological Oncology Group is a not-for-profit organisation dedicated to gynaecological cancer research. This research is in all forms of gynaecological malignancies and is conducted with multicentre institutional involvement by over 51 sites throughout Australia and New Zealand. The clinical trial program involves the evaluation of novel therapies in gynaecological cancer as well as research for the prevention and mitigation of gynaecological malignancies. The aim is to facilitate improvements of treatment into practice, with the minimal delay. ANZGOG members come from all medical disciplines and share a passion for clinical trials research with a view to increasing the range of treatments available to women with gynaecological cancers. The group is promotes public education and awareness of gynaecological cancers and their treatment. It involves consumers as members and on its advisory panel for consumer outreach and trial development. ANZGOG is a health promotion charity with approval to fundraise in most states of Australia.
A committed group of cancer specialists believed the most effective means to increase cancer cures was through clinical trials research, so they established the ANZ Gynaecological Oncology Group in 2000. Today ANZGOG is the lead group for gynaecological cancer clinical trials in Australia and New Zealand and has implemented 16 trials across more than 51 hospitals. Now women here have the same opportunities to participate in important gynaecological cancer clinical trials as do women overseas. Our research is in ovarian cancer, cervical cancer, cancer of the uterus, v***a and va**na. Our aim is to improve the outcomes and quality of life for women with gynaecological cancers. Apart from clinical trials, we do this by involving consumers and the community in outreach programs and trial development. We also exchange the latest in clinical practice at the Annual Scientific Meeting, provide professional education and publish research results.
